Search details
1.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(12): 1399-1410, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38039993
2.
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias.
Blood
; 123(21): 3296-304, 2014 May 22.
Article
in English
| MEDLINE | ID: mdl-24723681
3.
Analysis of pediatric autologous PBSC apheresis and transplant: age is a major factor affecting post-transplant toxicity.
Pediatr Blood Cancer
; 59(2): 301-5, 2012 Aug.
Article
in English
| MEDLINE | ID: mdl-22180259
4.
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.
Cardiovasc Intervent Radiol
; 45(4): 405-412, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35119481
5.
CD34⺠collection efficiency as a function of blood volumes processed in pediatric autologous peripheral blood stem cell collection.
J Clin Apher
; 26(3): 131-7, 2011.
Article
in English
| MEDLINE | ID: mdl-21294153
6.
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma.
J Clin Oncol
; 38(26): 2960-2970, 2020 09 10.
Article
in English
| MEDLINE | ID: mdl-32716739
7.
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
J Clin Invest
; 127(7): 2705-2718, 2017 Jun 30.
Article
in English
| MEDLINE | ID: mdl-28628042
8.
Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity.
Oncoimmunology
; 5(9): e1211221, 2016.
Article
in English
| MEDLINE | ID: mdl-27757306
9.
T cell receptor mimic antibodies for cancer therapy.
Oncoimmunology
; 5(1): e1049803, 2016.
Article
in English
| MEDLINE | ID: mdl-26942058
10.
Sequence context modulates the stability of a GxxxG-mediated transmembrane helix-helix dimer.
J Mol Biol
; 341(4): 991-8, 2004 Aug 20.
Article
in English
| MEDLINE | ID: mdl-15289100
11.
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.
Nat Biotechnol
; 33(10): 1079-86, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26389576
12.
Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.
Clin Cancer Res
; 20(15): 4036-46, 2014 Aug 01.
Article
in English
| MEDLINE | ID: mdl-24850840
13.
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
J Clin Invest
; 127(9): 3557, 2017 09 01.
Article
in English
| MEDLINE | ID: mdl-28862643
Results
1 -
13
de 13
1
Next >
>>